JPWO2021071977A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021071977A5 JPWO2021071977A5 JP2022520980A JP2022520980A JPWO2021071977A5 JP WO2021071977 A5 JPWO2021071977 A5 JP WO2021071977A5 JP 2022520980 A JP2022520980 A JP 2022520980A JP 2022520980 A JP2022520980 A JP 2022520980A JP WO2021071977 A5 JPWO2021071977 A5 JP WO2021071977A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- agonist
- antigen
- glycero
- palmitoyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962912005P | 2019-10-07 | 2019-10-07 | |
| US62/912,005 | 2019-10-07 | ||
| PCT/US2020/054621 WO2021071977A1 (en) | 2019-10-07 | 2020-10-07 | In vitro methods and compositions for enhancing the activation of dendritic cells and t cells, and for inducing a th-1 immune response |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022552200A JP2022552200A (ja) | 2022-12-15 |
| JPWO2021071977A5 true JPWO2021071977A5 (cs) | 2023-10-18 |
Family
ID=75437644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520980A Pending JP2022552200A (ja) | 2019-10-07 | 2020-10-07 | 樹状細胞およびＴ細胞の活性化を増強するためのならびにＴＨ－１免疫応答を誘導するためのｉｎ ｖｉｔｒｏの方法および組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240122975A1 (cs) |
| EP (1) | EP4041298A1 (cs) |
| JP (1) | JP2022552200A (cs) |
| KR (1) | KR20220098351A (cs) |
| CN (1) | CN115461073A (cs) |
| AU (1) | AU2020363707A1 (cs) |
| BR (1) | BR112022006743A2 (cs) |
| CA (1) | CA3157004A1 (cs) |
| IL (1) | IL292009A (cs) |
| MX (1) | MX2022004186A (cs) |
| WO (1) | WO2021071977A1 (cs) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114980928A (zh) * | 2019-11-18 | 2022-08-30 | 儿童医学中心公司 | 过度活化的树突状细胞可实现持久的基于过继性细胞转移的抗肿瘤免疫 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2018501322A (ja) * | 2015-01-12 | 2018-01-18 | チルドレンズ メディカル センター コーポレーション | トール様受容体４アンタゴニストの炎症促進性およびアジュバント機能 |
| RU2749610C2 (ru) * | 2015-09-15 | 2021-06-16 | Нортвест Байотерапьютикс, Инк. | Способы, относящиеся к композициям активированных дендритных клеток и к иммунотерапевтическому лечению индивидуумов с прогрессирующим раком |
-
2020
- 2020-10-07 JP JP2022520980A patent/JP2022552200A/ja active Pending
- 2020-10-07 MX MX2022004186A patent/MX2022004186A/es unknown
- 2020-10-07 IL IL292009A patent/IL292009A/en unknown
- 2020-10-07 AU AU2020363707A patent/AU2020363707A1/en active Pending
- 2020-10-07 BR BR112022006743A patent/BR112022006743A2/pt unknown
- 2020-10-07 WO PCT/US2020/054621 patent/WO2021071977A1/en unknown
- 2020-10-07 US US17/766,904 patent/US20240122975A1/en active Pending
- 2020-10-07 EP EP20875158.6A patent/EP4041298A1/en active Pending
- 2020-10-07 KR KR1020227014944A patent/KR20220098351A/ko unknown
- 2020-10-07 CA CA3157004A patent/CA3157004A1/en active Pending
- 2020-10-07 CN CN202080084824.5A patent/CN115461073A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liau et al. | Treatment of intracranial gliomas with bone marrow—derived dendritic cells pulsed with tumor antigens | |
| Hegmans et al. | Immunotherapy of murine malignant mesothelioma using tumor lysate–pulsed dendritic cells | |
| JP5816627B2 (ja) | 抗原特異的ｔ細胞の増殖のための方法 | |
| ES2766299T3 (es) | Composiciones y procedimientos para la activación linfocitaria de células dendríticas monocíticas y células T para generar una respuesta Th-1 | |
| JP2001509135A (ja) | 混合リンパ球と組み合わせた腫瘍細胞を用いるガン免疫療法 | |
| RO120579B1 (ro) | Utilizarea ligandului flt3 | |
| EP2534242B1 (en) | Improved composition for inhibiting tumor cell proliferation | |
| WO2009040413A2 (en) | An ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases | |
| JP2024019229A (ja) | 進行したがんを有する被験体のための活性化樹状細胞組成物および免疫療法処置に関する方法 | |
| WO2004053095A2 (en) | In situ maturation of dendritic cells | |
| JP2002509717A (ja) | 抑制された単球由来細胞、それらの調製法及びそれらの医薬組成物における使用 | |
| AU2003246396B2 (en) | A method for generating antigen-presenting cells | |
| WO2002053176A2 (en) | An autologous anti-cancer vaccine | |
| JP2002509715A (ja) | 刺激された単球に由来する細胞、その調製及び用途 | |
| JPWO2021071977A5 (cs) | ||
| US20240122975A1 (en) | In vitro methods and compositions for enhancing the activation of dendritic cells and t cells, and for inducing a th-1 immune response | |
| CN115920019A (zh) | 一种治疗肺癌及其骨转移的mRNA疫苗及其制备方法与应用 | |
| US20060073589A1 (en) | Rapid generation of activated mononuclear antigen presenting cells from monocytes | |
| JP2002510642A (ja) | ヒト患者における抗原提示細胞および抗腫瘍応答の増強法 | |
| Jacobs et al. | Endocrine organs under the control of the immune system: potential implications for cellular therapies | |
| WO2016135286A1 (en) | Method for stimulating dendritic cells (dcs) | |
| US20170298083A1 (en) | New immunostimulatory compounds | |
| Shahum et al. | Effect of liposomal antigens on the priming and activation of the immune system by dendritic cells | |
| Liu et al. | Potent in vivo anti-tumor activity of isolated CD62Llow lymph node cells sensitized in vivo with tumor lysate-pulsed DC-based vaccines | |
| KR20160116978A (ko) | 활성화 b 세포를 이용한 항원 특이적 세포 독성 t 세포 제조 방법 및 그 용도 |